Orally administered activated charcoal as a medical countermeasure for acute radiation syndrome in rats
dc.contributor.author | Snezhkova, Elisaveta | |
dc.contributor.author | Rodionova, Natalia | |
dc.contributor.author | Bilko, Denys | |
dc.contributor.author | Silvestre-Albero, JoaquĆn | |
dc.contributor.author | Sydorenko, Alexey | |
dc.contributor.author | Yurchenko, Olga | |
dc.contributor.author | Pakharenko, Marharyta | |
dc.contributor.author | Alavijeh, Mohammad | |
dc.contributor.author | Bardakhivska, Kvitoslava | |
dc.contributor.author | Riabchenko, Natalia | |
dc.contributor.author | Nikolaev, Volodymyr | |
dc.date.accessioned | 2021-11-16T21:41:26Z | |
dc.date.available | 2021-11-16T21:41:26Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Activated charcoal (AC) can be taken orally as enterosorbent for treatment of pathological states related to exogenous and endogenous intoxications. Synthesized granulated AC with a highly developed active surface (SBET ~2700 m2/g) was used as a medical countermeasure (MCM) to acute radiation sickness (ARS) in rats after total body X-ray irradiation. AC demonstrates positive results in ARS treatment, as expressed in, (i) a decrease in body weight loss, (ii) a protection of bone marrow (BM) cells colony formation capacity, (iii) a reduction of BM chromosomal aberrations and small intestine and spleen tissue damage, (iv) an amelioration of white blood cell count, and (v) a mitigation of superoxide ion generation rate in the liver. AC oral prescription seems to be perspective modality of ARS treatment. | en |
dc.identifier.citation | Orally administered activated charcoal as a medical countermeasure for acute radiation syndrome in rats [electronic resource] / Snezhkova E., Rodionova N., Bilko D., Silvestre-Albero J., Sydorenko A., Yurchenko O., Pakharenko M., Alavijeh M., Bardakhivska K., Riabchenko N., Nikolaev V. // Applied Sciences : open access journal. - 2021. - Vol. 11, Issue 7. - Article number 3174. | en |
dc.identifier.uri | https://doi.org/10.3390/app11073174 | |
dc.identifier.uri | https://ekmair.ukma.edu.ua/handle/123456789/21553 | |
dc.language.iso | en | uk_UA |
dc.relation.source | Applied Sciences : open access journal. | ru |
dc.status | first published | uk_UA |
dc.subject | activated charcoal | en |
dc.subject | enterosorbent | en |
dc.subject | acute radiation sickness | en |
dc.subject | rats | en |
dc.subject | article | en |
dc.title | Orally administered activated charcoal as a medical countermeasure for acute radiation syndrome in rats | en |
dc.type | Article | uk_UA |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Orally_administered_activated_charcoal_as_a_medical_countermeasure.pdf
- Size:
- 3.2 MB
- Format:
- Adobe Portable Document Format
- Description:
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 7.54 KB
- Format:
- Item-specific license agreed upon to submission
- Description: